EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 31, Issue 7, Pages 1547-1554
Publisher
Springer Nature
Online
2016-11-28
DOI
10.1038/leu.2016.359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
- (2016) F. Nadeu et al. BLOOD
- Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors
- (2016) L.-A. Sutton et al. HAEMATOLOGICA
- Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
- (2016) H Parker et al. LEUKEMIA
- DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
- (2016) Christopher C Oakes et al. NATURE GENETICS
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors
- (2016) L.-A. Sutton et al. HAEMATOLOGICA
- Essential control of early B-cell development by Mef2 transcription factors
- (2015) J. Herglotz et al. BLOOD
- Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia
- (2015) D. Rodriguez et al. BLOOD
- Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
- (2015) V. Ljungstrom et al. BLOOD
- Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
- (2015) Larry Mansouri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Non-coding recurrent mutations in chronic lymphocytic leukaemia
- (2015) Xose S. Puente et al. NATURE
- Mutations driving CLL and their evolution in progression and relapse
- (2015) Dan A. Landau et al. NATURE
- The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia
- (2015) Lesley-Ann Sutton et al. SEMINARS IN CANCER BIOLOGY
- Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
- (2015) Kati Kämpjärvi et al. Oncotarget
- Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans
- (2015) Yi Xia et al. Oncotarget
- Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution
- (2015) L.-A. Sutton et al. HAEMATOLOGICA
- Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
- (2014) S. Stilgenbauer et al. BLOOD
- Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness
- (2014) M. Messina et al. BLOOD
- The frequency ofTP53gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors
- (2014) Jitka Malcikova et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting
- (2014) L.-A. Sutton et al. HAEMATOLOGICA
- Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression
- (2014) J Ojha et al. LEUKEMIA
- Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
- (2014) J Malcikova et al. LEUKEMIA
- Recurrent mutations refine prognosis in chronic lymphocytic leukemia
- (2014) P Baliakas et al. LEUKEMIA
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
- (2014) F. Damm et al. Cancer Discovery
- BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
- (2013) F. Damm et al. BLOOD
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
- (2013) Dan A. Landau et al. CELL
- ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin
- (2013) V. Navrkalova et al. HAEMATOLOGICA
- Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
- (2013) J C Strefford et al. LEUKEMIA
- SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
- (2013) S Jeromin et al. LEUKEMIA
- POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
- (2013) Andrew J Ramsay et al. NATURE GENETICS
- Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
- (2012) F. Damm et al. BLOOD
- Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns
- (2012) A. Schuh et al. BLOOD
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
- (2012) D. G. Oscier et al. BLOOD
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells
- (2012) Suling Li et al. IMMUNITY
- Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
- (2012) Anna Skowronska et al. JOURNAL OF CLINICAL ONCOLOGY
- Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies
- (2012) F Damm et al. LEUKEMIA
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- (2010) Heng Li et al. BIOINFORMATICS
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
- (2009) Prateek Kumar et al. Nature Protocols
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Erk Kinases Link Pre-B Cell Receptor Signaling to Transcriptional Events Required for Early B Cell Expansion
- (2008) Tomoharu Yasuda et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search